Regardless of the excessive hopes for the brand new assessments, there are a lot of questions.
Some critics say {that a} deal with treating youthful individuals is misplaced as a result of they might not adjust to taking a statin or one other drug for the remainder of their lives. It may be troublesome for younger individuals to deal with potential threats to their well being a long time sooner or later, and a few of Dr. Rader’s sufferers have postpone even getting polygenic danger assessments after he recommends them.
The actual want, these critics say, is with the massive group of older individuals who want cholesterol-lowering therapy however will not be getting it, or who’re abandoning their prescriptions. In a single research, about 40 p.c of individuals 65 and older who had a coronary heart assault and wish lipid-lowering medicines for the remainder of their lives cease taking statins inside two years.
Others, like Dr. Rita F. Redberg, a heart specialist on the College of California, San Francisco, the editor at JAMA Inner Medication and a critic of the overuse of statins, is anxious that polygenic danger scores may introduce new issues.
“There’s lots of draw back to labeling individuals with a illness,” she stated.
The label, she added, “inexorably results in assessments and a seek for remedies.” And, she stated, “as a result of the individual, who now has turn out to be a ‘affected person,’ is asymptomatic, extra assessments and potential remedies usually is not going to make the individual really feel any higher.”
Folks can go from pondering of themselves as wholesome to pondering of themselves as somebody with a illness. “Now, at any time when they expertise the frequent aches, pains and twinges of life, they surprise whether it is as a result of they’ve this ‘illness,’” Dr. Redberg stated. “They usually might then go to the physician and even emergency room for issues they’d not have beforehand. And that additionally will result in extra assessments and procedures, with their attendant danger of harms.”
Others, whereas enthusiastic concerning the prospects for polygenic danger scores, say that medical doctors have to know extra about how efficient early intervention may be.
Dr. Iftikhar Kullo of the Mayo Clinic in Rochester, Minn., requested, “Do you really enhance long-term outcomes” by utilizing the assessments and appearing on them?
